Development
Ekso Bionics Holdings, Inc.
EKSO
$3.14
-$0.11-3.39%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -15.20M | -15.16M | -16.10M | -14.85M | -15.08M |
| Total Depreciation and Amortization | 1.70M | 1.28M | 1.11M | 1.07M | 887.00K |
| Total Amortization of Deferred Charges | 0.00 | 240.00K | 159.00K | 0.00 | 0.00 |
| Total Other Non-Cash Items | 2.03M | 1.38M | 1.67M | 1.50M | 2.09M |
| Change in Net Operating Assets | -583.00K | -1.86M | -187.00K | -2.42M | -2.58M |
| Cash from Operations | -12.05M | -14.11M | -13.35M | -14.70M | -14.69M |
| Capital Expenditure | -157.00K | -167.00K | -291.00K | -236.00K | -194.00K |
| Sale of Property, Plant, and Equipment | -- | 19.00K | 19.00K | 19.00K | 19.00K |
| Cash Acquisitions | -- | -5.00M | -5.00M | -5.00M | -5.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -157.00K | -5.15M | -5.27M | -5.22M | -5.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -313.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 661.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 348.00K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -24.00K | 19.00K | 18.00K | 14.00K | -18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.89M | -19.24M | -18.61M | -19.90M | -19.88M |